DMC Group’s Moderna MRNA Stock Holding History

DMC Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$563K	Buy	+2,922	New	+$315K	0.39%	73
2024 Q4	–	Sell	-4,859	Closed	-$325K	–	135
2024 Q3	$325K	Sell	4,859 -4,554	-48%	-$418K	0.26%	105
2024 Q2	$1.12M	Buy	9,413 +827	+10%	+$105K	0.96%	32
2024 Q1	$915K	Buy	8,586 +870	+11%	+$87.7K	0.79%	43
2023 Q4	$767K	Buy	7,716 +927	+14%	+$78K	0.73%	47
2023 Q3	$701K	Buy	6,789 +887	+15%	+$98.9K	0.66%	52
2023 Q2	$717K	Buy	5,902 +690	+13%	+$92K	0.72%	48
2023 Q1	$831K	Buy	5,212 +82	+2%	+$13.5K	0.84%	38
2022 Q4	$918K	Buy	5,130 +1,189	+30%	+$194K	1.04%	24
2022 Q3	$477K	Buy	3,941 +2,019	+105%	+$306K	0.58%	50
2022 Q2	$283K	Buy	+1,922	New	+$275K	0.34%	84

Other funds holding MRNA

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

DMC Group's MRNA Position: Q3 2026 in Review

DMC Group opened a new position in Moderna (MRNA) in Q3 2026: 2,922 shares worth $563K. The stake represents 0.39% of the portfolio and ranks #73 among its holdings. This is a return to the name: DMC Group previously reported a position in MRNA as recently as Q3 2024.

DMC Group first reported a position in MRNA in Q2 2022 and has held it in 11 quarters since. The position peaked at $1.12M in Q2 2024. 304 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

DMC Group held 2,922 shares of Moderna worth $563K as of Q3 2026.
Moderna was a new DMC Group position in Q3 2026.
Moderna made up 0.39% of DMC Group's portfolio in Q3 2026, its #73 holding.
DMC Group first reported a position in Moderna in Q2 2022 and has held it in 11 quarters since.
DMC Group's Moderna position peaked at $1.12M in Q2 2024.
304 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on DMC Group's 13F filing for Q3 2026, filed 26 Oct 2026.